Trevi Therapeutics (TRVI) Institutional Ownership → After Conviction, More Bad News for Trump (From Paradigm Press) (Ad) Free TRVI Stock Alerts $2.44 -0.03 (-1.21%) (As of 06/7/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Trevi Therapeutics (NASDAQ:TRVI)CurrentInstitutional OwnershipPercentage95.76%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$4.83MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$4.36M Get TRVI Insider Trade Alerts Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRVI Institutional Buying and Selling by Quarter Ad Paradigm PressTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25. Trevi Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2024 Opaleye Management Inc.2,645,000$9.13M2.0%+4.3%3.756% 5/15/2024 Price T Rowe Associates Inc. MD13,561$47K0.0%N/A0.019% 5/14/2024 Propel Bio Management LLC260,000$897K0.5%N/A0.369% 5/10/2024 Vanguard Group Inc.2,303,648$7.95M0.0%+2.7%3.271% 5/7/2024 Oppenheimer & Co. Inc.60,415$208K0.0%N/A0.086% 5/7/2024 SG Americas Securities LLC14,592$50K0.0%-85.1%0.021% Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/1/2024 BNP Paribas Financial Markets20,577$71K0.0%-84.4%0.030% 4/25/2024 Rosalind Advisors Inc.926,016$3.20M3.0%-50.3%1.343% 2/15/2024 Opaleye Management Inc.2,535,000$3.40M0.9%+48.6%3.970% 2/15/2024 Frazier Life Sciences Management L.P.7,381,090$9.89M0.5%+7.3%11.559% 2/5/2024 WealthTrust Axiom LLC63,500$85K0.0%-32.1%0.099% 1/12/2024 SG Americas Securities LLC98,253$132K0.0%+401.4%0.154% 1/4/2024 Trust Co. of Toledo NA OH36,502$49K0.0%-68.8%0.057% 11/13/2023 Silverarc Capital Management LLC927,415$2.02M0.6%+4.7%1.452% 10/20/2023 Trust Co. of Toledo NA OH117,145$255K0.1%-6.2%0.183% 10/13/2023 SG Americas Securities LLC19,597$43K0.0%N/A0.031% 9/21/2023 Barclays PLC14,052$34K0.0%N/A0.022% 8/11/2023 VR Adviser LLC3,422,397$8.18M1.3%+12.2%5.697% 8/11/2023 Tejara Capital Ltd180,227$431K0.2%-5.3%0.300% 8/4/2023 American International Group Inc.20,037$48K0.0%N/A0.033% 8/3/2023Innovis Asset Management LLC43,232$103K0.0%-50.5%0.072% 8/2/2023 MAI Capital Management1,534,652$3.67M0.1%-4.1%2.555% 7/10/2023 Trust Co. of Toledo NA OH124,857$298K0.1%+50.4%0.208% 5/12/2023 Tejara Capital Ltd190,218$352K0.2%+26.8%0.317% 5/10/2023 MAI Capital Management1,600,415$2.96M0.0%-7.0%2.664% 4/4/2023 Trust Co. of Toledo NA OH83,000$154K0.0%N/A0.138% 2/10/2023 Opaleye Management Inc.485,000$936K0.3%N/A0.809% 2/9/2023 MAI Capital Management1,720,676$3.32M0.1%-14.8%2.872% 2/3/2023 Frazier Life Sciences Management L.P.6,663,590$12.86M0.8%+23.3%11.121% 2/2/2023 Bailard Inc.21,200$41K0.0%N/A0.035% 2/1/2023 Bank of Montreal Can152,300$294K0.0%N/A0.254% 11/15/2022 TPG GP A LLC251,780$388K0.0%-94.2%0.571% 11/14/2022 Armistice Capital LLC864,000$1.33M0.0%+107.7%1.961% 11/14/2022 Altium Capital Management LP1,066,157$1.64M0.6%-17.0%2.419% 11/14/2022 Rubric Capital Management LP5,684,420$8.75M0.4%+219.6%12.899% 11/10/2022 Hillsdale Investment Management Inc.86,531$133K0.0%N/A0.196% 11/9/2022 Fairmount Funds Management LLC5,696,515$8.77M1.5%+250.7%12.926% 11/7/2022 Jump Financial LLC42,977$66K0.0%N/A0.098% 10/28/2022 Silverarc Capital Management LLC939,265$1.45M0.5%N/A2.131% 8/15/2022 Acuta Capital Partners LLC35,000$98K0.1%N/A0.090% Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER…8/10/2022 Frazier Life Sciences Management L.P.1,171,627$3.29M0.3%N/A3.029% 7/27/2022 WealthTrust Axiom LLC93,500$262K0.1%-5.1%0.242% 7/19/2022 MAI Capital Management2,040,009$5.73M0.1%+32.3%5.273% 5/10/2022 MAI Capital Management1,541,471$3.39M0.1%N/A3.985% 5/9/2022 WealthTrust Axiom LLC98,500$216K0.1%+245.6%0.255% 5/4/2022Commonwealth Equity Services LLC15,000$33K0.0%N/A0.049% 8/17/2021 Bridgeway Capital Management LLC34,600$78K0.0%-68.4%0.160% 8/16/2021 Alberta Investment Management Corp25,000$56K0.0%N/A0.116% 8/13/2021 Renaissance Technologies LLC92,600$208K0.0%-24.0%0.429% 5/21/2021 Citadel Advisors LLC10,617$29K0.0%N/A0.053% 5/18/2021 Citadel Advisors LLC10,617$29K0.0%N/A0.053% 5/13/2021 Renaissance Technologies LLC121,849$330K0.0%+374.1%0.611% 5/7/2021 BlackRock Inc.32,394$87K0.0%+40.6%0.163% 4/14/2021 WealthTrust Axiom LLC38,500$104K0.0%+234.8%0.193% 3/26/2021Susquehanna International Group LLP14,828$36K0.0%N/A0.081% 2/17/2021 Canada Pension Plan Investment Board15,000$36K0.0%N/A0.082% 2/10/2021 Renaissance Technologies LLC25,700$62K0.0%N/A0.140% 2/4/2021 WealthTrust Axiom LLC11,500$27K0.0%N/A0.063% 8/31/2020 Bridgeway Capital Management Inc.100,000$658K0.0%+33.3%0.548% 8/17/2020 Omega Fund Management LLC1,375,907$9.05M2.5%+8.9%7.711% 8/14/2020 Canada Pension Plan Investment Board40,000$263K0.0%N/A0.224% 8/14/2020TPG Group Holdings SBS Advisors Inc.4,824,883$31.75M0.6%-23.7%27.039% 8/5/2020 NEA Management Company LLC5,940,796$39.09M1.6%+33.8%33.293% 5/15/2020 Driehaus Capital Management LLC117,371$386K0.0%-6.1%0.658% (Data available from 1/1/2016 forward) TRVI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRVI shares? During the previous two years, 28 institutional investors and hedge funds held shares of Trevi Therapeutics. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($9.89M), Opaleye Management Inc. ($9.13M), Fairmount Funds Management LLC ($8.77M), Rubric Capital Management LP ($8.75M), VR Adviser LLC ($8.18M), Vanguard Group Inc. ($7.95M), and MAI Capital Management ($3.67M).Learn more on TRVI's institutional investors. What percentage of Trevi Therapeutics stock is owned by institutional investors? 95.76% of Trevi Therapeutics stock is owned by institutional investors. Learn more on TRVI's institutional investor holdings. Which institutional investors have been buying Trevi Therapeutics stock? Of the 22 institutional investors that purchased Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fairmount Funds Management LLC ($4.07M), Rubric Capital Management LP ($3.91M), Frazier Life Sciences Management L.P. ($2.93M), Opaleye Management Inc. ($1.42M), Silverarc Capital Management LLC ($980.76K), MAI Capital Management ($498.54K), and Armistice Capital LLC ($448K). How much institutional buying is happening at Trevi Therapeutics? Institutional investors have bought a total of 15,663,214 shares in the last 24 months. This purchase volume represents approximately $28.18M in transactions. Which Trevi Therapeutics major shareholders have been selling company stock? Of the 10 institutional investors that sold Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: TPG GP A LLC ($4.07M), Rosalind Advisors Inc. ($936.41K), MAI Capital Management ($484.51K), Altium Capital Management LP ($217.84K), BNP Paribas Financial Markets ($111.63K), Trust Co. of Toledo NA OH ($88.36K), and SG Americas Securities LLC ($83.66K). How much institutional selling is happening at Trevi Therapeutics? Institutional investors have sold a total of 6,084,643 shares in the last 24 months. This volume of shares sold represents approximately $11.78M in transactions. Related Companies: VNDA Major Shareholders CARA Major Shareholders SAGE Major Shareholders LYEL Major Shareholders SLN Major Shareholders HROW Major Shareholders ALXO Major Shareholders DNTH Major Shareholders ANAB Major Shareholders AVBP Major Shareholders This page (NASDAQ:TRVI) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredSecret energy grid to power millions of homesThis high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type ...Porter & Company | SponsoredMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.